Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options.

Schmid, Jonas Andreas; Festl, Yasmin; Severin, Yannik; Bacher, Ulrike; Kronig, Marie-Noëlle; Snijder, Berend; Pabst, Thomas

Schmid, Jonas Andreas; Festl, Yasmin; Severin, Yannik; Bacher, Ulrike; Kronig, Marie-Noëlle; Snijder, Berend; Pabst, Thomas.

Affiliation

Schmid JA; Faculty of Medicine University of Bern, Bern.
Festl Y; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich.
Severin Y; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich.
Bacher U; Department of Hematology; Inselspital, University Hospital Bern, University of Bern, Bern.
Kronig MN; Department of Medical Oncology; Inselspital, University Hospital Bern, University of Bern, Bern.
Snijder B; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich. snijder@imsb.biol.ethz.ch.
Pabst T; Department of Medical Oncology; Inselspital, University Hospital Bern, University of Bern, Bern.

Haematologica ; 109(2): 617-621, 2024 Feb 01.

Article de En | MEDLINE | ID: mdl-37439341

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde Limites: Humans Langue: En Journal: Haematologica Année: 2024 Type de document: Article Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google